Generics Lowering Part D Rx Costs, CMS Reports

AUGUST 01, 2006
p align=justify> Although critics of the new Medicare Part D drug benefit are pushing for changes in the program to lower costs to seniors, officials at the Centers for Medicare & Medicaid Services (CMS) contend that the program is already cutting prescription costs far more than originally expected.

According to CMS, strong competition among competing Part D prescription drug plans has enabled Medicare patients to see "deep discounts on their drugs at their local pharmacies," with much of the savings coming as a result of generic drugs. "In many cases, beneficiaries are using the unprecedented price information provided by Medicare to get much larger savings by switching to lower-cost drugs," CMS said. "Many beneficiaries?have switched to generic drugs, obtaining even deeper discounts on their drug costs."




SHARE THIS SHARE THIS
0
 

The Oncology Care Pharmacist in Health-System Pharmacy 
According to the National Cancer Institute, almost 40% of men and women will be given a diagnosis of some form of cancer in their lifetime.


 

 

Conference Coverage
News from the year's biggest meetings


Pharmacist Education
Clinical features with downloadable PDFs


 

SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.